Combining Targeted Agents With Modern Radiotherapy in Soft Tissue Sarcomas-Reference-Cited by-同舟云学术

Combining Targeted Agents With Modern Radiotherapy in Soft Tissue Sarcomas

Published:2014-10-18 Issue:11 Volume:106 Page:dju329-dju329
ISSN:0027-8874
Container-title:JNCI Journal of the National Cancer Institute
language:en
Short-container-title:JNCI Journal of the National Cancer Institute

Author:

Wong P.,Houghton P.,Kirsch D. G.,Finkelstein S. E.,Monjazeb A. M.,Xu-Welliver M.,Dicker A. P.,Ahmed M.,Vikram B.,Teicher B. A.,Coleman C. N.,Machtay M.,Curran W. J.,Wang D.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/106/11/dju329/7678901/dju329.pdf

Reference166 articles.

1. Opportunities and Challenges in the Era of Molecularly Targeted Agents and Radiation Therapy

2. NCI–RTOG Translational Program Strategic Guidelines for the Early-Stage Development of Radiosensitizers

3. Clinicopathologic Re-Evaluation of 100 Malignant Fibrous Histiocytomas: Prognostic Relevance of Subclassification

4. Coordinated expression and amplification of theMDM2,CDK4, andHMGI-C genes in atypical lipomatous tumours

5. Sarcoma Diagnosis in the Age of Molecular Pathology

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LncRNAs as potential prognosis/diagnosis markers and factors driving drug resistance of osteosarcoma, a review;Frontiers in Endocrinology;2024-07-02

2. Unraveling the Myth of Radiation Resistance in Soft Tissue Sarcomas;Seminars in Radiation Oncology;2024-04

3. Current stand on systemic therapy in localized soft tissue sarcomas: a clinician's perspective;Future Oncology;2023-10

4. A novel inflammatory signature for evaluating immune microenvironment status in soft tissue sarcoma;Frontiers in Oncology;2022-10-13

5. Prognostic Assessment in High-Grade Soft-Tissue Sarcoma Patients: A Comparison of Semantic Image Analysis and Radiomics;Cancers;2021-04-16